709
Views
131
CrossRef citations to date
0
Altmetric
Review

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach

, , , , , , , , & show all
Pages 3111-3128 | Published online: 02 May 2019

Figures & data

Figure 1 Mechanism of action of siRNA molecules. SiRNA duplexes are incorporated in the RNA-induced silencing complex (RISC). Then, siRNA are unwinded and the strand with lower thermodynamic stability at its 5’end remains in the complex and guides it to the complementary mRNA. The target mRNA is then cleaved and protein expression is abolished or reduced.

Figure 1 Mechanism of action of siRNA molecules. SiRNA duplexes are incorporated in the RNA-induced silencing complex (RISC). Then, siRNA are unwinded and the strand with lower thermodynamic stability at its 5’end remains in the complex and guides it to the complementary mRNA. The target mRNA is then cleaved and protein expression is abolished or reduced.

Figure 2 A schematic image of LNPs siRNA showing a nanostructured core.

Figure 2 A schematic image of LNPs siRNA showing a nanostructured core.

Table 1 Summary of siRNA-loaded encapsulated liposomes utilized for siRNA delivery

Figure 3 A schematic representation of several strategies for encapsulating siRNA in liposomes.

Figure 3 A schematic representation of several strategies for encapsulating siRNA in liposomes.

Figure 4 Schematic illustration of a Cyclodextrin structure.

Figure 4 Schematic illustration of a Cyclodextrin structure.

Figure 5 A schematic representation of a dendrimer showing the central core, the peripherical sites, and the consecutive generations.

Figure 5 A schematic representation of a dendrimer showing the central core, the peripherical sites, and the consecutive generations.

Table 2 Intracellular and extracellular limitations of RNAi

Table 3 Selection of clinical trials against cancer using siRNA drugs